Assignee
EA PHARMA CO LTD
JP·17 granted patents·11 pending applications·39 citations·filing 2012–2024
Top patents by PatentIndex Score
28 records- 0185USRE49569EAlkylamine derivativeEA PHARMA CO LTD·Filed 2021·Granted Jul 4, 2023·1 cites·20 claims
- 0282US9533985B2Sulfonamide derivative and medicinal use thereofEA PHARMA CO LTD·Filed 2013·Granted Jan 3, 2017·15 cites·15 claims
- 0381US10562898B2Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activityEA PHARMA CO LTD·Filed 2017·Granted Feb 18, 2020·5 cites·20 claims
- 0481US9822110B2Sulfonamide derivative and pharmaceutical use thereofEA PHARMA CO LTD·Filed 2016·Granted Nov 21, 2017·6 cites·27 claims
- 0580US10626112B2Heterocyclic sulfonamide derivative and medicine comprising sameEA PHARMA CO LTD·Filed 2016·Granted Apr 21, 2020·2 cites·10 claims
- 0673US10166234B2Pharmaceutical preparation comprising phenylalanine derivativeEA PHARMA CO LTD·Filed 2018·Granted Jan 1, 2019·1 cites·13 claims
- 0773US9562043B2Heterocyclic amide derivative and pharmaceutical product containing sameEA PHARMA CO LTD·Filed 2014·Granted Feb 7, 2017·3 cites·11 claims
- 0870US9655879B2Heteroarylcarboxylic acid ester derivativeEA PHARMA CO LTD·Filed 2015·Granted May 23, 2017·1 cites·14 claims
- 0969US10183022B2Pharmaceutical composition for treating ulcerative colitisEA PHARMA CO LTD·Filed 2017·Granted Jan 22, 2019·2 cites·11 claims
- 1068US10039763B2Pharmaceutical preparation comprising phenylalanine derivativeEA PHARMA CO LTD·Filed 2012·Granted Aug 7, 2018·1 cites·17 claims
- 1166US11311508B2Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysisEA PHARMA CO LTD·Filed 2018·Granted Apr 26, 2022·1 cites·15 claims
- 1257US2024262805A1Method for producing compound or pharmaceutically acceptable salt thereofEA PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 1356US10226400B2Multi-cell containerEA PHARMA CO LTD·Filed 2013·Granted Mar 12, 2019·1 cites·10 claims
- 1456US9440980B2Remedy for diabetesEA PHARMA CO LTD·Filed 2014·Granted Sep 13, 2016·0 cites·18 claims
- 1556US2021206773A1Drug for treating disorders of corneal epitheliumEA PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1655US12023320B2Therapeutic agent for fatty liver diseaseEA PHARMA CO LTD·Filed 2023·Granted Jul 2, 2024·0 cites·11 claims
- 1749US2018230122A1Production method for heteroarylcarboxylic acid ester derivative, production intermediate thereof, and crystalEA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1845US10584116B2Heterocyclic sulfonamide derivative and medicine containing sameEA PHARMA CO LTD·Filed 2018·Granted Mar 10, 2020·0 cites·19 claims
- 1945US2017369494A1Drug for treating disorders of corneal epitheliumEA PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 2045US2016376249A1Production method for heteroarylcarboxylic acid ester derivative, production intermediate thereof, and crystalEA PHARMA CO LTD·Filed 2016·Application pending·0 cites
- 2144US2022142958A1Medicinal composition having excellent stabilityEA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2242US2018162844A1Cyclopropane derivative and drug containing sameEA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 2341US2017151200A1Prophylactic or therapeutic agent for idiopathic inflammatory myopathiesEA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 2437US2020229955A1Stent and medical device comprising sameEA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2533US9883986B2Standing bag type infusion liquid containerEA PHARMA CO LTD·Filed 2014·Granted Feb 6, 2018·0 cites·9 claims
- 2633US2017143738A1Solid formulation and method for stabilizing the sameEA PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 2731US10420741B2Megalin antagonistEA PHARMA CO LTD·Filed 2016·Granted Sep 24, 2019·0 cites·11 claims
- 2826US2016376248A1Method for producing heteroarylcarboxylic acid ester derivative, and production intermediate of sameEA PHARMA CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EA PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →